Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YOSEMITE: RO6867461 vs Aflibercept in Diabetic Macular Edema
2017-005104-10Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2018
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of faricimab in diabetic macular edema (DME), sponsored by Roche. Started Sep 2018; status: completed.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2017-005104-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005104-10.